Personalizing GLP-1 Treatment: Genetic Insights Into Stress Pathways PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and examines genetic variants that influence how individuals respond to GLP-1 agonists and manage stress hormones
A breakdown of the most common plateau types, from water-weight plateaus to intake drift and low-movement stalls
further reading Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising (Forbes)
GLP-1 drugs have recently been linked by regulators to significant health and safety concerns, and the Health Canada-approved product monograph for Ozempic has been revised to add warnings about gastrointestinal harms and gallbladder disease
But the move eliminated the one functioning middle ground in the regulatory landscape: licensed compounding pharmacies, where physicians could order peptides for specific patients under real quality controls, sterility testing, and genuine medical oversight
Indi B: a new benchmark T dwarf